US Patent 7498322 Antiangiogenic agents
Patent 7498322 was granted and assigned to EntreMed on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Anthony M. Treston0
Gregory E. Agoston0
Jamshed H. Shah0
Lita Suwandi0
Theresa M. LaVallee0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+195 characters)
Article
Patent abstract
Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae:
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07498322 Antiangiogenic agents US Patent 7498322 Antiangiogenic agents
Infobox
Patent Number
07498322
Patent Number
7498322
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07498322 Antiangiogenic agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07498322
Date of patent
March 3, 2009
Patent application number
11077977
Date Filed
March 11, 2005
Patent primary examiner
Find more entities like US Patent 7498322 Antiangiogenic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.